Irbesartan for heart failure with preserved ejection fraction.
Ghali
Jalal K
JK
D000740:Anemia / Q000150:complications; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D006333:Heart Failure / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D000077405:Irbesartan; D007674:Kidney Diseases / Q000150:complications; D012720:Severity of Illness Index; D013318:Stroke Volume; D013777:Tetrazoles / Q000627:therapeutic use*; D017211:Treatment Failure
D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D013777:Tetrazoles; D003404:Creatinine; D000077405:Irbesartan